The rising prevalence of cancer across the globe further provide significant demand of live cell imaging that further contribute in the growth of the market. According to the World Health Organization (WHO), cancer is the second leading cause of mortality across the globe which is responsible for around 9.6 million mortalities and accounted for 18.1 million new cases in 2018, globally. 1 in 5 men and 1 in 6 women, worldwide, develop cancer during their lifetime, and 1 in 8 men and 1 in 11 women die from the disease. Globally, the total number of people who are alive within 5 years of a cancer diagnosis, called the 5-year prevalence, is estimated to be 43.8 million. The live cell imaging is being used widely in the form of models to investigate disease mechanism and to develop therapies. The models based on 3D cell culture technology generates biological information in order to facilitate medical solutions promising preclinical drugs.
Browse the full report description of "Global Live Cell Imaging Market Size, Share & Trends Analysis Report by Product (Instruments, Consumables, and Software & Services), By Application (Stem Cells, Drug Discovery, Cell Biology, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Research Institutes, and Contract Research Organizations) and Forecast 2019-2025" at https://www.omrglobal.com/industry-reports/live-cell-imaging-market
Technological development in cell culture technology spur the live cell imaging market
Cell-based assays have been widely used in drug discovery for the last several years. In the recent years, 2D monolayer cells cultured were the only convenient and effective means for drug discovery on a variety of planar substrates. Nowadays, 2D cell models are being very useful in drug discovery due to its efficient prediction in-vivo drug responses for many targets and pathways. However, the advent of 3D cell cultures is evident that these 2D cultures suffer disadvantages associated with the loss of tissue-specific architecture, cell-to-cell, and cell-to-matrix interactions, to predict drug responses for certain diseases such as cancer they are not suitable models. 3D cell cultures are being highly implemented in early drug discovery with the help of 3D high content screening (HCS), fueled by the need to continuously improve the productivity of pharmaceutical R&D.
The integration of cell models such as stem cells with 3D cell cultures allows enhanced predictability of toxicity in humans before the drugs are moved into clinical trials which in turn reduce the attrition rate of new medicines under development. Thus, the advanced diagnosis and drug development with 3D cell culture over the 2D cell culture is giving the edge to 3D cell culture which in turn, motivating the market growth for live cell imaging. Moreover, cancer research has progressed over recent years, and a new dimension of research has been discovered by the advent of 3D cell culture techniques. Cancer cell lines have been used to study the complex physiology of cancers due to ease and flexibility. With 3D cell culture techniques, there have been significant advancements in which the cell lines can be utilized to carry out cancer research.
Global live cell imaging Market Segmentation
By Product
By Application
By End-User
Global live cell imaging Market – Segment by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/live-cell-imaging-market